| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/04/2001 | CN1063969C Process for preparing pharmaceutically composition containing poly peptides |
| 04/04/2001 | CN1063941C Stable compositons for parenteral administration and method of making same |
| 04/03/2001 | US6211517 Electron beam fault detection of semiconductor devices |
| 04/03/2001 | US6211352 Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 04/03/2001 | US6211342 Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function |
| 04/03/2001 | US6211341 Antibody which binds blood coagulation factor; for use as a antithrombolytic agent |
| 04/03/2001 | US6211337 RIP: novel human protein involved in tumor necrosis factor signal transduction |
| 04/03/2001 | US6211336 Ataxia-telangiectasia gene |
| 04/03/2001 | US6211334 Cell-cycle regulatory proteins, and uses related thereto |
| 04/03/2001 | US6211273 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 04/03/2001 | US6211235 Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211164 Sensitization of tumor cells |
| 04/03/2001 | US6211163 Injection; sustained release of expressed protein |
| 04/03/2001 | US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus |
| 04/03/2001 | US6211157 Administering bone-derived protein; ultrafiltration, ion exchanging, liquid chromatography |
| 04/03/2001 | US6211156 Peptides for treatment of erectile dysfunction |
| 04/03/2001 | US6211155 Stimulating immune system with peptides conjugated with mono-or dicarboxylic acid; |
| 04/03/2001 | US6211154 Peptide anticoagulants |
| 04/03/2001 | US6211153 Methods for treating LHRH associated disorders with LHRH antagonists |
| 04/03/2001 | US6211152 Formulations for peptide release |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6211150 Analogs of cationic proteins |
| 04/03/2001 | US6211149 Inhibitors of formation of protease resistant prion protein |
| 04/03/2001 | US6211148 Antimicrobial peptides from bovine neutrophis |
| 04/03/2001 | US6211147 Method of promoting angiogenesis using relaxin |
| 04/03/2001 | US6211146 60A protein-induced morphogenesis |
| 04/03/2001 | US6211145 Bicyclic depsipeptides |
| 04/03/2001 | US6211144 Stable concentrated insulin preparations for pulmonary delivery |
| 04/03/2001 | US6211143 Administering composition containing hydrolyzed gelatin, b vitamins and source of magnesium |
| 04/03/2001 | US6211142 Compositions comprising gas6 polypeptides and articles of manufacture comprising the same |
| 04/03/2001 | US6210974 Compositions and methods for promoting nerve regeneration |
| 04/03/2001 | US6210968 DNA molecules encoding pgp3 protein from Chlamydia trachomatis |
| 04/03/2001 | US6210967 DNA encoding a mammalian LPA receptor and uses thereof |
| 04/03/2001 | US6210963 Autologous differentiated tissue aggregates; for the treatment of tumors; antitumor agents |
| 04/03/2001 | US6210962 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof |
| 04/03/2001 | US6210960 Nucleotide sequence coding polypeptide which activates somatostatin promote; for the treatment of diabetes |
| 04/03/2001 | US6210946 Modified adenovirus containing a fiber replacement protein |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210941 Methods for the detection and isolation of proteins |
| 04/03/2001 | US6210939 Recombinant adenoviral vector and methods of use |
| 04/03/2001 | US6210929 Fusion protein of furin with catalytic center and c-terminal deletion, flexible peptide spacer, and histidine-tag affinity peptide; for proteolytic processing/activation of recombinant proteins |
| 04/03/2001 | US6210927 Polynucleotides encoding sbGnRH, a novel reproductive hormone |
| 04/03/2001 | US6210926 Activating apoptosis in cell infected with herpes by in vitro administration of agent that inhibits infected cell protein-4 function |
| 04/03/2001 | US6210925 Direct expression of peptides into culture media |
| 04/03/2001 | US6210921 CAR: a novel coxsackievirus and adenovirus receptor |
| 04/03/2001 | US6210920 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 04/03/2001 | US6210919 Genetic sequences and proteins related to alzheimer's disease |
| 04/03/2001 | US6210918 Detecting level of nitric oxide, arginine or citrulline, or activity or expression of nitric oxide synthase, or conversion of nitric oxide to nitrate and nitrite in sample, and comparing to non-laboring pregnant female |
| 04/03/2001 | US6210913 Modulation of integrin-mediated signal transduction |
| 04/03/2001 | US6210904 Diagnosing for risk of thromocytopenia by detecting absence of association of monoclonal antibody with glycoprotein iib/iia receptor:glycoprotein iib/iia receptor antagonist complex |
| 04/03/2001 | US6210892 Hybridizing an antisense compound having a 2' sugar, morpholino, or peptide nucleic acid modification to target messenger rna to change its processing including splicing, polyadenylation or stability |
| 04/03/2001 | US6210890 Human peroxisomal thioesterase |
| 04/03/2001 | US6210887 Methods for evaluating colon tissue for expression of the DRA (down regulated in adenoma) gene |
| 04/03/2001 | US6210883 Compounds and methods for diagnosis of lung cancer |
| 04/03/2001 | US6210742 Emulsions are suited for preparation of food products, personal care products, pharmaceutical products and industrial products |
| 04/03/2001 | US6210697 Medicament for hypothermia treatment |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |
| 04/03/2001 | US6210676 Compositions and methods using the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein C (OspC) for the diagnosis and prevention of lyme disease |
| 04/03/2001 | US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide |
| 04/03/2001 | US6210674 GreA from Staphylococcus aureus |
| 04/03/2001 | US6210673 gidB from Staphylococcus aureus |
| 04/03/2001 | US6210671 Complementarity determining regions corresponding to mouse dreg-55 donor immunoglobulin; heavy and light chain variable region frameworks corresponding to gal antibody human acceptor immunoglobulin heavy and light chain frameworks |
| 04/03/2001 | US6210670 Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin |
| 04/03/2001 | US6210669 Methods and compositions for immunomodulation |
| 04/03/2001 | US6210668 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies |
| 04/03/2001 | US6210667 Relates to modifications of streptokinase and other microbial enzymes for use to activate plasminogen in the presence of fibrin, to efficiently dissolve an unwanted blood clot in a subject. |
| 04/03/2001 | US6210666 Truncated α-galactosidase A to treat fabry disease |
| 04/03/2001 | US6210661 IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections |
| 04/03/2001 | US6210654 Jak kinases and regulation of cytokine signal transduction |
| 04/03/2001 | US6210394 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 04/03/2001 | CA2224795C Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/03/2001 | CA2211120C Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/03/2001 | CA2210996C Liquid formulations for proteinic pharmaceuticals |
| 04/03/2001 | CA2196795C Method for diagnosing a predisposition for breast and ovarian cancer |
| 04/03/2001 | CA2194228C Fusion proteins comprising gm-csf and antigens and their expression in yeast |
| 04/03/2001 | CA2153180C Interleukin 4 signal transducers and binding assays |
| 03/30/2001 | WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 03/30/2001 | CA2384139A1 Interfering with telomere maintenance in treatment of diseases |
| 03/30/2001 | CA2321379A1 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 03/30/2001 | CA2283538A1 New hev antigenic peptide and methods |
| 03/29/2001 | WO2001022093A1 Method for monitoring treatment with a parathyroid hormone |
| 03/29/2001 | WO2001022091A2 Method for determining the fertility of mammals, especially of humans |
| 03/29/2001 | WO2001021836A2 Molecules for diagnostics and therapeutics |
| 03/29/2001 | WO2001021831A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 03/29/2001 | WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | WO2001021816A1 MODULATION OF IgE RECEPTOR CELL SURFACE EXPRESSION |
| 03/29/2001 | WO2001021814A1 Heparanase-2, a member of the heparanase protein family |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021802A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021801A1 Gene treatment to enhance feed efficiency and growth rate of livestock |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021795A2 Fatty acid transport proteins |
| 03/29/2001 | WO2001021794A2 Smad associating polypeptides |
| 03/29/2001 | WO2001021793A1 p21Cip1 REMEDIES FOR RHEUMATISM |
| 03/29/2001 | WO2001021791A2 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides |
| 03/29/2001 | WO2001021790A1 Conditional immortalisation of cells |
| 03/29/2001 | WO2001021789A1 Ribozymes used for restenosis prevention |
| 03/29/2001 | WO2001021787A1 Polypeptide humanin inhibiting nerve cell death |